Clinical trial
Romiplostim in Combination With Ciclosporin Versus Ciclosporin in the Treatment of Newly Diagnosed Non-severe Aplastic Anemia
NCT06009497 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Romiplostim in Combination With Ciclosporin Versus Ciclosporin in the Treatment of Newly Diagnosed Non-severe Aplastic Anemia
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2023
- Completion date
- December 31, 2025
- Enrollment
- 44 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non severe aplastic anemia